 |
 |
이름 |
발음 |
[1][2] |
IUPAC 이름
(8R,9S,13S,14S,17S)-13-Methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol |
별칭
Oestradiol; E2; 17β-Estradiol; Estra-1,3,5(10)-triene-3,17β-diol; 17β-Oestradiol |
식별자 |
|
|
|
|
ChEBI |
|
ChEMBL |
|
ChemSpider |
|
DrugBank |
|
ECHA InfoCard |
100.000.022 |
KEGG |
|
|
|
UNII |
|
|
|
InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1 예 Key: VOXZDWNPVJITMN-ZBRFXRBCSA-N 예
|
C[C@]12CC[C@@H]3c4ccc(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O
|
성질 |
|
C18H24O2 |
몰 질량 |
272.38 g/mol |
|
-186.6·10−6 cm3/mol |
약리학 |
|
G03CA03 (WHO) |
라이선스 데이터 |
|
투여경로 |
Oral, sublingual, intranasal, topical/transdermal, vaginal, intramuscular or subcutaneous (as an ester), subdermal implant |
약물동태학: |
|
Oral: <5%[3] |
단백결합 |
~98%:[3][4] • Albumin: 60% • SHBG: 38% • Free: 2% |
|
Liver (via hydroxylation, sulfation, glucuronidation) |
|
Oral: 13–20 hours[3] Sublingual: 8–18 hours[5] Topical (gel): 36.5 hours[6] |
|
Urine: 54%[3] Feces: 6%[3] |
달리 명시된 경우를 제외하면, 표준상태(25 °C [77 °F], 100 kPa)에서 물질의 정보가 제공됨.
|